John C Jacobs
President and CEO, Director at Novavax Inc (NVAX) since January 2023
John C Jacobs has filed 20 insider reports with the SEC since September 2021, as president and CEO and director at Novavax Inc (NVAX) and officer and director at Harmony Biosciences Holdings, Inc. (HRMY). John C Jacobs made no open-market purchases or sales in the last 12 months. The latest filing, on March 9, 2026, reports grant or award at Novavax Inc (NVAX).
- Filings
- 20
- Companies
- 2
- Bought on market
- None
- Sold on market
- $8.78M
Companies where John C Jacobs is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEO, Directorsince January 2023 | 225,680 | $7.47 | Mar 9, 2026 | ||||
| Officer, Director | 0 | $8.78M | $32.59 | Aug 16, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 2, 2026NVAXAmendment: SEC Form 4 filed by President and CEO Jacobs John CForm 4Grant or award
- Mar 3, 2026NVAXPresident and CEO Jacobs John C converted options into 150,167 shares and covered exercise/tax liability with 69,288 shares, increasing direct ownership by 98% to 225,680 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 2, 2026NVAXPresident and CEO Jacobs John C converted options into 83,333 shares and covered exercise/tax liability with 38,450 shares, increasing direct ownership by 25% to 225,680 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 23, 2026NVAXPresident and CEO Jacobs John C covered exercise/tax liability with 39,132 shares and converted options into 83,197 shares, increasing direct ownership by 32% to 180,797 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 3, 2025NVAXSEC Form 4 filed by President and CEO Jacobs John CForm 4Grant or award
- Mar 1, 2025NVAXPresident and CEO Jacobs John C converted options into 83,334 shares and covered exercise/tax liability with 38,451 shares, increasing direct ownership by 49% to 136,732 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 23, 2025NVAXPresident and CEO Jacobs John C converted options into 83,196 shares and covered exercise/tax liability with 38,873 shares, increasing direct ownership by 93% to 91,849 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2024NVAXSEC Form 4 filed by Jacobs John CForm 4Grant or award
- Jan 23, 2024NVAXJacobs John C converted options into 83,197 shares and covered exercise/tax liability with 40,093 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 23, 2023NVAXSEC Form 4 filed by Jacobs John CForm 4Grant or award
- Jan 23, 2023NVAXJohn C Jacobs became an insiderForm 3New insider
- Aug 15, 2022-$2.04MHRMYSEC Form 4: Jacobs John C exercised 40,000 shares at a strike of $8.22 and sold $2,042,813 worth of shares (40,000 units at $51.07) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 15, 2022-$681KHRMYSEC Form 4: Jacobs John C exercised 15,000 shares at a strike of $8.22 and sold $681,277 worth of shares (15,000 units at $45.42) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 13, 2022-$1.1MHRMYSEC Form 4: Jacobs John C exercised 25,000 shares at a strike of $8.22 and sold $1,104,411 worth of shares (25,000 units at $44.18) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 16, 2022-$680KHRMYSEC Form 4: Jacobs John C exercised 15,000 shares at a strike of $8.22 and sold $679,821 worth of shares (15,000 units at $45.32) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 14, 2022-$1.06MHRMYSEC Form 4: Jacobs John C exercised 25,000 shares at a strike of $8.22 and sold $1,059,772 worth of shares (25,000 units at $42.39) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 4, 2022-$1.3MHRMYSEC Form 4: Jacobs John C exercised 28,700 shares at a strike of $8.22 and sold $1,295,985 worth of shares (28,700 units at $45.16) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 27, 2021-$58.5KHRMYSEC Form 4: Jacobs John C exercised 1,300 shares at a strike of $8.22 and sold $58,538 worth of shares (1,300 units at $45.03) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 13, 2021-$955KHRMYSEC Form 4: Jacobs John C exercised 25,000 shares at a strike of $8.22 and sold $955,409 worth of shares (25,000 units at $38.22) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 13, 2021-$898KHRMYSEC Form 4: Jacobs John C exercised 25,000 units of Common Stock at a strike of $8.22 and sold $898,262 worth of Common Stock (25,000 units at $35.93)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
Compare John C Jacobs with
- John C Jacobs vs Kumar Budur1 shared
- John C Jacobs vs Sandip Kapadia1 shared
- John C Jacobs vs Richard J Rodgers1 shared
- John C Jacobs vs Rachel K. King1 shared
- John C Jacobs vs Richard Douglas1 shared
- John C Jacobs vs Margaret G Mcglynn1 shared
Other insiders at the same companies
- Kumar BudurHRMY
- Stephen M. MollichellaHRMY
- Sandip KapadiaHRMY
- Richard J RodgersNVAX
- Rachel K. KingNVAX
- Richard DouglasNVAX
- Margaret G McglynnNVAX
- David M MottNVAX
- Gregg H AltonNVAX
- John W. ShiverNVAX
- Charles W. NewtonNVAX
- Geno J GermanoHRMY
- Linda M SzyperHRMY
- Ron M PhilipHRMY
- R. Mark GrafHRMY
- Juan A. SabaterHRMY
Questions about John C Jacobs
- What is John C Jacobs's role at Novavax Inc?
- John C Jacobs reports to the SEC as president and CEO and director at Novavax Inc (NVAX), according to the latest filing on March 9, 2026. John C Jacobs has also filed as officer and director at Harmony Biosciences Holdings, Inc. (HRMY).
- How many shares does John C Jacobs own?
- After the latest filing that states it, John C Jacobs directly owned 225,680 shares of Novavax Inc (NVAX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has John C Jacobs bought or sold stock recently?
- The most recent open-market sale was on August 15, 2022: sold 40,000 shares of Harmony Biosciences Holdings, Inc. (HRMY) for $2.04M at an average of $51.07.
- How do I get alerts when John C Jacobs files?
- Follow John C Jacobs on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by John C Jacobs (SEC CIK 0001820836). Totals count each trade once, skipping amendments whose original is on file, from Sep 14, 2021 on. View on SEC EDGAR · Get this as JSON